TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
4.040
-0.080 (-1.94%)
Nov 21, 2024, 1:08 PM EST - Market open
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $215.62 million as of November 21, 2024. Its market cap has increased by 9.98% in one year.
Market Cap
215.62M
Enterprise Value
39.12M
1-Year Change
9.98%
Ranking
Category
Stock Price
$4.04
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $215.62M, a decrease of -39.95%. That is a compound annual growth rate of -14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 219.89M | -21.14% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 225.30M |
| aTyr Pharma | 224.36M |
| Inogen | 223.89M |
| Zentalis Pharmaceuticals | 219.85M |
| Genfit | 218.94M |
| Sutro Biopharma | 217.69M |
| Utah Medical Products | 216.93M |
| biote | 215.83M |